AOL Money & Finance

NOA posts

Feed

Analyst upgrades, downgrades and initiations: DUK, ETFC, MOT, MTB, SBUX

Analyst Upgrades

  • Baird upgraded Starbucks (NASDAQ: SBUX) to Outperform from Neutral based on field research that indicates improving traffic trends and visibility from cost savings initiatives.
  • FBR Capital upgraded E*Trade (NASDAQ: ETFC) to Outperform from Underperform citing an attractive risk/reward following the company's capital raise and debt exchange commencement. The firm believes the worst is behind the company and has a $2 target on the stock.
  • Oppenheimer upgraded Sonic (NASDAQ: SONC) to Outperform from Perform on expectations demand trends will improve, leading to more normalized profitability.
  • Estee Lauder (NYSE: EL) was upgraded to Equal Weight from Underweight at Barclays.
  • Motorola (NYSE: MOT) was upgraded to Buy from Neutral at BofA/Merrill.
  • ConAgra (NYSE: CAG) was upgraded to Buy from Neutral at UBS.

Continue reading Analyst upgrades, downgrades and initiations: DUK, ETFC, MOT, MTB, SBUX

Analyst upgrades, downgrades and initiations: BAC, ERIC, UNH, WRC

Analyst upgrades:
  • Keefe Bruyette upgraded Bank of America (NYSE:BAC) to Outperform from Market Perform due to valuation and the company's better balance sheet following capital raises. The firm raised its target on shares to $16.50.
  • Merriman upgraded Blue Coat Systems (NASDAQ:BCSI) to Buy from Neutral to reflect stabilizing demand and merger synergies from the Packeteer acquisition.
  • Thomas Weisel upgraded Genomic Health (NASDAQ:GHDX) to Overweight from Market Weight based on valuation, a new colon cancer assay expected in 2010, and upside from new sales hires.
  • Plexus (NASDAQ:PLXS) was upgraded to Outperform from Neutral at Baird.
  • Great Plains Energy (NYSE:GXP) was raised to Buy from Neutral at Goldman.
  • Ericsson (nASDAQ:ERIC) was upgraded at Societe Generale to Buy from Hold.

Continue reading Analyst upgrades, downgrades and initiations: BAC, ERIC, UNH, WRC

IPO & secondary preview -- Week of July 30, 2007

Wall Street's equity market offers a solid slate this week with 7 IPOs and 4 Secondaries on the docket. Those deals tentatively scheduled to price include:

IPOs:

Thursday
  • Amedica (AMCA), a 4.65M-share IPO for this artificial joints company. Morgan Stanley, Goldman Sachs, and Lehman Brothers are the lead managers. Filing range: $13.00-$15.00.
  • Concho Resources (CXO), a 21.2M-share IPO for this oil and gas company. JP Morgan Chase, Bank of America and Lehman Brothers are the lead managers. Filing range: $14.00-$16.00.
  • Dolan Media (DM), a 10.5M-share IPO for this media services company. Goldman Sachs and Merrill Lynch are the lead managers. Filing range: $13.50-$15.50.
  • Genpact (G), a 35.3M-share IPO for this information technology services company. Morgan Stanley, Citigroup, and JP Morgan Chase are the lead managers. Filing range: $16.00-$18.00.
  • NanoDynamics (NDMX), a 6.6M-share IPO for this specialty chemicals company. Jefferies is the lead manager. Filing range: $12.00-$14.00.
  • Sucampo Pharmaceuticals (SCMP), a 3.75M-share IPO for this pharmaceutical company. Cowen is the lead manager. Filing range: $14.00-$16.00.
  • Virtusa (VRTU), a 4.4M-share IPO for this information technology services company. JP Morgan Chase is the lead manager. Filing range: $14.00-$16.00.

Continue reading IPO & secondary preview -- Week of July 30, 2007

Symbol Lookup
IndexesChangePrice
DJIA+44.2910,291.26
NASDAQ+15.822,166.90
S&P 500+5.501,098.51

Last updated: November 11, 2009: 09:44 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance